Frank Bretz

Frank Bretz

Novartis
Verified email at novartis.com
Cited by 31109
clinical trials multiple testing adaptive designs dose finding
Assaf P. Oron

Assaf P. Oron

Senior Analyst, IHME Client Services, University of Washington
Verified email at uw.edu
Cited by 4824
Dose-finding Spatial Models up-and-down Environmental Health Global Health
Sarah Zohar

Sarah Zohar

INSERM
Verified email at inserm.fr
Cited by 4745
dose-finding phase I phase II clinical trials biostatistics
Nolan A. Wages, Ph.D.

Nolan A. Wages, Ph.D.

Professor, Department of Biostatistics, Virginia Commonwealth University
Verified email at vcuhealth.org
Cited by 1665
Biostatistics Clinical trial design Dose-finding Cancer
Pavel Mozgunov

Pavel Mozgunov

Programme Leader Track at MRC Biostatistics Unit
Verified email at mrc-bsu.cam.ac.uk
Cited by 644
Early Phase Clinical Trials Adaptive Designs Medical Statistics Biostatistics Dose Finding
Hongtao Zhang

Hongtao Zhang

Merck
Verified email at merck.com
Cited by 545
Bayesian statistics adaptive designs dose finding
Jinjie chen

Jinjie chen

Senior Manager Statistics, BMS
Verified email at bms.com
Cited by 279
Bayesian Statistics Dose Finding Dose Optimization Probability of Trial Success
Hao Sun

Hao Sun

Biostatistician, Bristol Myers Squibb
Verified email at bms.com
Cited by 8
Clinical Trial Design Dose Finding Dose Optimization Dynamic Borrowing Group Sequential Design
Renata Eirini Tsirpitzi

Renata Eirini Tsirpitzi

Statistician at SDS Life science - A Cytel company
Verified email at sdslifescience.com
Cited by 5
Statistics Optimal Design Dose-finding